Silver Book Fact

After 9 years of tight blood pressure control, patients with type 2 diabetes had a 34% reduction in retinopathy progression and a 47% reduction in risk of visual acuity deterioration by three lines, when they had a 10/5 mmHg reduction in blood pressure.

Turner R, Holman R, Stratton I, Cull C, et al. Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes. BMJ. 1998; 317(7160): 703-13. http://www.bmj.com/cgi/content/abstract/317/7160/703

Reference

Title
Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes
Publication
BMJ
Publication Date
1998
Authors
Turner R, Holman R, Stratton I, Cull C, et al
Volume & Issue
Volume 317, Issue 7160
Pages
703-13
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Screening and treatment of diabetic retinopathy in type 2 diabetes patients produces annual savings of $247.9 million to the federal budget– in 1994 dollars.  
  • Women taking vitamins B6 and B12 and folic acid–as compared to women not taking these supplements–were found to have a 34% lower risk of age-related macular degeneration (AMD) and a…  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…  
  • Screening and treatment for diabetic retinopathy in type 2 diabetes patients produces annual savings of 53,986 person-years of sight.  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.